A colorectal cancer screening technology focused on replacing FOBT workdwide.
DiagNodus Ltd (“DiagNodus”) is a biomedical technology start-up working in the field of early detection of colorectal cancer (CRC). DiagNodus is seeking to develop and commercialise Screen2C™. Screen2C™ is a developed method for population screening for CRC that addresses the need for a fully non-invasive, easy-to-use, self administering screening kit for individuals over the age of 50. 1.3 million new CRC cases were diagnosed worldwide in 2010,